SAN DIEGO, Oct. 27, 2015 (GLOBE NEWSWIRE) -- Real Scientific Hemp Oil™ (RSHO™), made by Medical Marijuana, Inc. (OTC Pink:MJNA), is making headline news as the U.S.’s first and largest legal hemp-based cannabis export. As reported by ABC 10 News, the all-natural, non-GMO hemp-based cannabidiol (CBD) oil product is now approved by the government of Brazil for import with approved in-country documentation. This historic shift in international cannabis law has made Brazil the largest single client for the San Diego-based company.
A photo accompanying this release is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/803fc12a-d7fb-432f-a5d2-e983431adf52
“San Diego is becoming a major hub for these hemp CBD products,” states Stuart W. Titus, PhD and Chief Executive Officer of Medical Marijuana, Inc., in the ABC 10 News interview.
The major change in international cannabis regulations is due to two little girls, Harper Howard age 5 and Anny Fischer age 6, from the U.S. and Brazil. Their mothers connected through the Hope4Harper.com Facebook support group for the rare genetic disorder: CDKL5 epilepsy. MJNA’s CBD hemp oil products are readily available in and ship to all U.S. states, territories, and districts. In contrast, hemp oil products are handled quite differently in Brazil and what resulted from the mothers’ online connection led to a new chapter in world history.
The Brazilian government, until recently, viewed anything made from cannabis – including non-psychoactive hemp – as illegal and, therefore, a controlled substance. The US has allowed hemp based products – hemp seed, hemp oil and hemp protein powder since the late 1990’s and a federal court ruling upheld this allowance of hemp nutritional products.
After hearing the testimony of the Fischer family and their daughter Anny’s need for RSHO, however, a Brazilian Federal Judge deemed it “inhumane” to keep it (RSHO hemp oil) from the little girl – as it was helping to alleviate the potentially fatal condition when no pharmaceutical medications were working. Then, after a series of historic rulings, ANVISA removed CBD from Brazil’s prohibited substance use list, removed the import tax and is actively subsidizing the cost for those who need financial assistance. (Note, perhaps we say botanical-based CBD in prior sentence).
Dr. Titus concludes, “The development opens up a potential future multimillion-dollar CBD hemp oil pipeline from San Diego to Brazil.”
Hemp is widely regarded as a “whole food” and “super food.” MJNA’s cannabidiol (CBD) hemp oil is derived from the mature stalk of the hemp plant and is considered a food nutrient delivering the benefits of cannabinoids without the psychotropic/euphoric effects of THC. The Company is committed to consistently providing the highest-quality CBD hemp oil products on the market.
About HempMeds Brasil and LLC HempMeds PX, LLC
HempMeds® is a corporate affiliated company of Medical Marijuana, Inc. (OTC Pink:MJNA) and is its exclusive distributor of RSHO™. HempMeds Brasil™ offers specialized marketing, sales, customer service, and logistics to supply natural hemp oil rich in CBD to the medical community and families of Brazil. For more information on HempMeds Brasil™ and their all-natural hemp oil products, visit: http://www.hempmeds.com.br. The Company invites the public to get involved in the conversation on the expanding cannabis industry with HempMeds Brasil™ through the Company’s social media channels Facebook, Twitter and blog.
About Medical Marijuana, Inc.
Our mission is to be the premier hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company's website at: www.MedicalMarijuanaInc.com.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The Company does grow, sell and distribute hemp-based products and are involved with the federally legal distribution of hemp-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
The photo is also available at Newscom, www.newscom.com, and via AP PhotoExpress.
For further information, please contact: Public Relations contact: Andrew Hard Spokesperson CMW Media P. 858-380-5478 firstname.lastname@example.org www.cmwmedia.com Corporate contact: Medical Marijuana, Inc. Toll Free: 888-OTC-MJNA (888-682-6562) www.medicalmarijuanainc.com www.facebook.com/mjnainc Investor Relations: GH Investment Advisors 550 West "C" Street, Ste. 2040 San Diego, CA 92101 Nick Massalas Office: (858) 264-6500 Toll Free: (877) 964-6463 email@example.com
Source:Medical Marijuana Inc